Trial Profile
A trial to study the efficacy and tolerability of mirabegron in multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 31 May 2016 New trial record
- 10 May 2016 Results presented at the 111th Annual Meeting of the American Urological Association